Snapshot · Philip Morris International Inc. (PM)

Data as of 2026-09-02T00:08:43.276Z

Fundamentals check

Market cap

$291.7B

P/E (TTM)

26.9

Gross margin

67.5%

Net margin

25.6%

ROE

-112.2%

R&D / revenue

0.0%

Dividend yield

3.1%

FCF yield

4.4%

Latest dividend: $1.47/share (ex-date 2026-06-25, quarterly)

Summary

Philip Morris International Inc. functions as a prominent tobacco enterprise, actively working toward a smoke-free future. The company is strategically diversifying its long-term product range to incorporate items beyond traditional tobacco and nicotine. Its primary business involves both conventional cigarettes and an expanding array of smoke-free alternatives, such as innovative heat-not-burn devices, vapor products, and oral nicotine solutions. These offerings are distributed in markets worldwide, with the exception of the United States. The smoke-free portfolio includes brands like HEETS (encompassing Creations, Dimensions, Marlboro variants), Parliament HeatSticks, and TEREA, in addition to KT&G-licensed brands Fiit and Miix. For conventional cigarettes, the company sells internationally recognized brands such as Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris. Regionally, it also owns major cigarette brands like Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia, and Fortune and Jackpot in the Philippines. PMI's smoke-free innovations are currently available across 71 global markets. Established in 1987, Philip Morris International Inc. is headquartered in New York, New York.

How it makes money

Revenue mix, latest fiscal year

• Combustible Products58.5%
• Reduced-Risk Products41.5%

Recent Events

• 2026-08-28T04:26:48.000Zpositive

  Ancora Advisors LLC Acquires Shares of 6,208 Philip Morris International Inc. $PM

  Ancora Advisors 增持信息可能与 PM 股价的正向波动相关，恰逢市场关注机构买入，但不能确认因果。

  Source: defenseworld.net

• 2026-08-25T10:46:19.000Zpositive

  Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets - Premium Price Tag

  对 PM 的烟草+无烟产品增长前景的乐观报道可能与股价上行相关，存在不确定性，不能断言因果。

  Source: seekingalpha.com

• 2026-08-24T12:06:04.000Zpositive

  Philip Morris' ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push

  FDA 授权11款 ZYN ULTRA 相关消息可能与 PM 短期上行动力相关，但非直接因果结论。

  Source: zacks.com

• 2026-08-24T00:00:00.000Zneutral

  PM filed 8-K

  PM 提交 8-K 的信息可能包含业绩/指引更新，可能与股价波动相关，但需要更多细节以确定因果。

  Source: SEC EDGAR

• 2026-08-17T00:00:00.000Znegative

  Price move: PM fell 3.1%

  PM 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-30T00:00:00.000Znegative

  Price move: PM fell 3.2%

  PM 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-16T00:00:00.000Zpositive

  Price move: PM rose 5.0%

  PM 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-09T00:00:00.000Znegative

  Price move: PM fell 3.2%

  PM 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-23T00:00:00.000Zpositive

  Price move: PM rose 3.2%

  PM 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $209.88 from 8 analysts (last quarter)

Insider & Congress activity

US Congress trading disclosures

• 2026-03-27Alan ArmstrongPurchase$1,001 - $15,000

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。